Results

1–3 of 3 results for Daniel F. Kiernan

Effect of Dexamethasone Intracameral Drug-Delivery Suspension on Central Retinal Thickness After Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2021
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated With Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
Annual Meeting Talks
2020
Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2019